Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Boffito

Showing results (81-90 of 300) with videos related to

Pageof 30
Sort By:
HIV Research & Clinical Practice|July 24, 2019
Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistatEmilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, et al.
HIV Medicine|October 22, 2025
Polypharmacy in HIV: Rethinking what counts and why it mattersLuxsena Sukumaran, Alan Winston, Catia Marzolini, et al.
AIDS Research and Human Retroviruses|October 15, 2021
Short Communication: Predictive Value of HIV-Related Versus Traditional Risk Factors for Coronary Atherosclerosis in People Aging with HIVBranca Pereira, Maria Mazzitelli, Ana Milinkovic, et al.
AIDS Care|June 4, 2021
Factors associated with overweight/obesity in a cohort of people living with HIV over 50 years of ageMaria Mazzitelli, Branca Isabel Pereira, Graeme Moyle, et al.
International Journal of STD & AIDS|November 28, 2023
Tackling late HIV diagnosis: Lessons from the UK in the COVID-19 eraEmily Boardman, Marta Boffito, David R Chadwick, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2022
Population Pharmacokinetic Model and Alternative Dosing Regimens for Dolutegravir Coadministered with RifampicinAida N Kawuma, Roeland E Wasmann, Kelly E Dooley, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylateMarta Boffito, Anton Pozniak, Brian P Kearney, et al.
AIDS Research and Human Retroviruses|March 19, 2002
Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatmentMarta Boffito, Antonella Rossati, Helen E Reynolds, et al.
AIDS (London, England)|July 2, 2014
Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicityJean C Yombi, Anton Pozniak, Marta Boffito, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2012
Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategiesAlessandro Schipani, Laura Dickinson, Marta Boffito, et al.
Pageof 30

Showing results (81-90 of 300) with videos related to

Sort By:
Pageof 30
HIV Research & Clinical Practice|July 24, 2019
Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistatEmilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, et al.
HIV Medicine|October 22, 2025
Polypharmacy in HIV: Rethinking what counts and why it mattersLuxsena Sukumaran, Alan Winston, Catia Marzolini, et al.
AIDS Research and Human Retroviruses|October 15, 2021
Short Communication: Predictive Value of HIV-Related Versus Traditional Risk Factors for Coronary Atherosclerosis in People Aging with HIVBranca Pereira, Maria Mazzitelli, Ana Milinkovic, et al.
AIDS Care|June 4, 2021
Factors associated with overweight/obesity in a cohort of people living with HIV over 50 years of ageMaria Mazzitelli, Branca Isabel Pereira, Graeme Moyle, et al.
International Journal of STD & AIDS|November 28, 2023
Tackling late HIV diagnosis: Lessons from the UK in the COVID-19 eraEmily Boardman, Marta Boffito, David R Chadwick, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2022
Population Pharmacokinetic Model and Alternative Dosing Regimens for Dolutegravir Coadministered with RifampicinAida N Kawuma, Roeland E Wasmann, Kelly E Dooley, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2005
Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylateMarta Boffito, Anton Pozniak, Brian P Kearney, et al.
AIDS Research and Human Retroviruses|March 19, 2002
Undefined duration of opiate withdrawal induced by efavirenz in drug users with HIV infection and undergoing chronic methadone treatmentMarta Boffito, Antonella Rossati, Helen E Reynolds, et al.
AIDS (London, England)|July 2, 2014
Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicityJean C Yombi, Anton Pozniak, Marta Boffito, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 27, 2012
Simultaneous population pharmacokinetic modelling of atazanavir and ritonavir in HIV-infected adults and assessment of different dose reduction strategiesAlessandro Schipani, Laura Dickinson, Marta Boffito, et al.
Pageof 30